LINDSAY LINDSEY: Open Payments
NPI 1548023948 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,146 in 213 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $2,707 · 2025 $4,146
Food & beverage: $4,085Education: $61
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 67 | $1,350 |
| Janssen Biotech, Inc. | 23 | $565 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $341 |
| Ardelyx, Inc. | 14 | $269 |
| QOL Medical, LLC | 8 | $229 |
| PFIZER INC. | 13 | $207 |
| Madrigal Pharmaceuticals | 8 | $195 |
| GENZYME CORPORATION | 5 | $145 |
| Gilead Sciences, Inc. | 8 | $140 |
| Phathom Pharmaceuticals, Inc. | 10 | $123 |
Products named: RINVOQ, TREMFYA, XIFAXAN, IBSRELA, LINZESS, Sucraid, DUPIXENT, REZDIFFRA.
Industry payments across KY — which companies pay providers there.
